Ishikawa T - Search Results

1

A case of hereditary metachronous bilateral triple-negative breast cancer that was highly sensitive to carboplatin.

Wu R, Adachi K, Koyama Y, Orimoto K, Okazaki M, Asaoka M, Teraoka S, Ueda A, Miyahara K, Kawate T, Kaise H, Yamada K, Sato E, Ishikawa T. Wu R, et al. Among authors: ishikawa t. J Surg Case Rep. 2021 Apr 14;2021(4):rjab018. doi: 10.1093/jscr/rjab018. eCollection 2021 Apr. J Surg Case Rep. 2021. PMID: 33884162 Free PMC article.

2

High levels of DJ-1 protein and isoelectric point 6.3 isoform in sera of breast cancer patients.

Kawate T, Iwaya K, Koshikawa K, Moriya T, Yamasaki T, Hasegawa S, Kaise H, Fujita T, Matsuo H, Nakamura T, Ishikawa T, Hiroi S, Iguchi-Ariga SM, Ariga H, Murota K, Fujimori M, Yamamoto J, Matsubara O, Kohno N. Kawate T, et al. Among authors: ishikawa t. Cancer Sci. 2015 Jul;106(7):938-43. doi: 10.1111/cas.12673. Epub 2015 May 6. Cancer Sci. 2015. PMID: 25867058 Free PMC article.

3

Prospective cohort study of febrile neutropenia in breast cancer patients with neoadjuvant and adjuvant chemotherapy: CSPOR-BC FN study.

Ishikawa T, Sakamaki K, Narui K, Kaise H, Tsugawa K, Ichikawa Y, Mukai H; for Comprehensive Support Project for Oncological Research of Breast Cancer. Ishikawa T, et al. Jpn J Clin Oncol. 2016 Jul;46(7):692-5. doi: 10.1093/jjco/hyw045. Epub 2016 May 9. Jpn J Clin Oncol. 2016. PMID: 27162322

4

Operation with less adjuvant therapy for elderly breast cancer.

Yamada A, Narui K, Sugae S, Shimizu D, Takabe K, Ichikawa Y, Ishikawa T, Endo I. Yamada A, et al. Among authors: ishikawa t. J Surg Res. 2016 Aug;204(2):410-417. doi: 10.1016/j.jss.2016.05.031. Epub 2016 May 26. J Surg Res. 2016. PMID: 27565077 Free PMC article.

5

Targeting bortezomib-induced aggresome formation using vinorelbine enhances the cytotoxic effect along with ER stress loading in breast cancer cell lines.

Miyahara K, Kazama H, Kokuba H, Komatsu S, Hirota A, Takemura J, Hirasawa K, Moriya S, Abe A, Hiramoto M, Ishikawa T, Miyazawa K. Miyahara K, et al. Among authors: ishikawa t. Int J Oncol. 2016 Nov;49(5):1848-1858. doi: 10.3892/ijo.2016.3673. Epub 2016 Aug 29. Int J Oncol. 2016. PMID: 27601063 Free PMC article.

6

Significant Effect of Polymorphisms in CYP2D6 on Response to Tamoxifen Therapy for Breast Cancer: A Prospective Multicenter Study.

Zembutsu H, Nakamura S, Akashi-Tanaka S, Kuwayama T, Watanabe C, Takamaru T, Takei H, Ishikawa T, Miyahara K, Matsumoto H, Hasegawa Y, Kutomi G, Shima H, Satomi F, Okazaki M, Zaha H, Onomura M, Matsukata A, Sagara Y, Baba S, Yamada A, Shimada K, Shimizu D, Tsugawa K, Shimo A, Tan EY, Hartman M, Chan CW, Lee SC, Nakamura Y. Zembutsu H, et al. Among authors: ishikawa t. Clin Cancer Res. 2017 Apr 15;23(8):2019-2026. doi: 10.1158/1078-0432.CCR-16-1779. Epub 2016 Oct 19. Clin Cancer Res. 2017. PMID: 27797974

7

Objection to postoperative radiation therapy in breast cancer with one to three lymph nodes involvements.

Ishikawa T, Kaise H, Yamada K, Hosonaga M, Chishima T, Narui K, Yamada A, Sugae S, Ichikawa Y, Ota M, Nozaki M, Mikami R, Tokuuye K. Ishikawa T, et al. Breast Cancer. 2017 Jul;24(4):496-501. doi: 10.1007/s12282-016-0749-5. Epub 2017 Jan 9. Breast Cancer. 2017. PMID: 28070832

8

Erratum to: Objection to postoperative radiation therapy in breast cancer with one to three lymph nodes involvements.

Ishikawa T, Kaise H, Yamada K, Hosonaga M, Chishima T, Narui K, Yamada A, Sugae S, Ichikawa Y, Ota M, Nozaki M, Mikami R, Tokuuye K. Ishikawa T, et al. Breast Cancer. 2017 Sep;24(5):732. doi: 10.1007/s12282-017-0792-x. Breast Cancer. 2017. PMID: 28688006 No abstract available.

9

Hereditary breast cancer associated with Cowden syndrome-related PTEN mutation with Lhermitte-Duclos disease.

Kimura F, Ueda A, Sato E, Akimoto J, Kaise H, Yamada K, Hosonaga M, Kawai Y, Teraoka S, Okazaki M, Ishikawa T. Kimura F, et al. Among authors: ishikawa t. Surg Case Rep. 2017 Dec;3(1):83. doi: 10.1186/s40792-017-0355-6. Epub 2017 Jul 24. Surg Case Rep. 2017. PMID: 28741261 Free PMC article.

10

Survival outcomes of neoadjuvant chemotherapy with zoledronic acid for HER2-negative breast cancer.

Ishikawa T, Akazawa K, Hasegawa Y, Tanino H, Horiguchi J, Miura D, Hayashi M, Kohno N. Ishikawa T, et al. J Surg Res. 2017 Dec;220:46-51. doi: 10.1016/j.jss.2017.05.066. Epub 2017 Jul 26. J Surg Res. 2017. PMID: 29180210 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

7,633 results

Search Page